Construction of a Database for the Life-cycle Sepsis-specific Disease Cohort
1 other identifier
observational
4,000
0 countries
N/A
Brief Summary
Establish a structured clinical database for sepsis screening, and establish a special data set standard for sepsis throughout the life cycle.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2021
CompletedFirst Posted
Study publicly available on registry
May 4, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedMay 4, 2021
April 1, 2021
1.3 years
April 10, 2021
May 2, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Sepsis organ function status and survival analysis.
Safety indicators include: prognosis: mortality, intensive care unit (ICU) treatment time and hospital stay, incidence of nosocomial infections, treatment-related complications.
2022.09.30
Eligibility Criteria
1-100 years
You may qualify if:
- Patients with sepsis who meet the Sepsis 3.0 standard proposed by the 2016 International Sepsis Expert Consensus, that is, for patients with infection or suspected infection, when sepsis-related sequential organ failure (Sequential (Sepsis-related) Organ Failure) Assessment (SOFA) score increased by ≥ 2 points from the baseline can be diagnosed as sepsis;
- It is estimated that the patient's ICU stay ≥24 hours;
- Obtain informed consent and sign an informed consent form.
You may not qualify if:
- The patient's ICU hospital stay is less than 24 hours;
- Participated in other clinical research;
- Failed to sign the informed consent form.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy Dean of Xinhua Hospital, Leader of Emergency Medicine Science Department
Study Record Dates
First Submitted
April 10, 2021
First Posted
May 4, 2021
Study Start
June 1, 2021
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
May 4, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share